These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 4198657)

  • 1. Immunity to brucella infection.
    Elberg SS
    Medicine (Baltimore); 1973 Jul; 52(4):339-56. PubMed ID: 4198657
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunological methods in brucellosis research. II. In vivo procedures.
    Olitzki A
    Bibl Microbiol; 1970; 9():1-299. PubMed ID: 4913957
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunobiological properties of the protective brucellosis antigen].
    Dranovskaia EA; Vershilova PA; Grekova NA
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Sep; (9):66-70. PubMed ID: 4216217
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the question of the characteristics of brucellae isolated on the territory of the USSR. II. Comparative virulence of different biotypes of the Brucella species melitensis, abortus and suis].
    Kaĭtmazova EI; Ostrovskaia NN
    Zh Mikrobiol Epidemiol Immunobiol; 1967 Feb; 44(2):66-70. PubMed ID: 4973047
    [No Abstract]   [Full Text] [Related]  

  • 5. Brucella abortus 2308ΔNodVΔNodW double-mutant is highly attenuated and confers protection against wild-type challenge in BALB/c mice.
    Li Z; Wang S; Zhang J; Yang G; Yuan B; Huang J; Han J; Xi L; Xiao Y; Chen C; Zhang H
    Microb Pathog; 2017 May; 106():30-39. PubMed ID: 28131952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally administrable brucellosis vaccine: Brucella suis strain 2 vaccine.
    Xin X
    Vaccine; 1986 Dec; 4(4):212-6. PubMed ID: 3541425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.
    Mailybayeva A; Yespembetov B; Ryskeldinova S; Zinina N; Sansyzbay A; Renukaradhya GJ; Petrovsky N; Tabynov K
    PLoS One; 2017; 12(10):e0186484. PubMed ID: 29023541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Completing the eradication of brucellosis by 1975.
    Schilf EA
    J Am Vet Med Assoc; 1972 Dec; 161(11):1525-7. PubMed ID: 4629394
    [No Abstract]   [Full Text] [Related]  

  • 9. Rough vaccines in animal brucellosis: structural and genetic basis and present status.
    Moriyón I; Grilló MJ; Monreal D; González D; Marín C; López-Goñi I; Mainar-Jaime RC; Moreno E; Blasco JM
    Vet Res; 2004; 35(1):1-38. PubMed ID: 15099501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzyme-linked immunosorbent assay to differentiate the antibody responses of animals infected with Brucella species from those of animals infected with Yersinia enterocolitica O9.
    Erdenebaatar J; Bayarsaikhan B; Watarai M; Makino S; Shirahata T
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):710-4. PubMed ID: 12853409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunity status of guinea pigs infected with Brucella L forms].
    Vershilova PA; Tolmacheva TA
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Sep; (9):107-9. PubMed ID: 6815938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Phenol-insoluble vaccine against human brucellosis: evaluation of the immunogenic power in guinea pigs].
    Bolpe J; de Lapenta DF; García-Carrillo C
    Rev Inst Med Trop Sao Paulo; 1991; 33(1):23-7. PubMed ID: 1843392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brucellosis vaccines based on the open reading frames from genomic island 3 of Brucella abortus.
    Gómez L; Alvarez F; Betancur D; Oñate A
    Vaccine; 2018 May; 36(21):2928-2936. PubMed ID: 29685597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prime-booster vaccination of cattle with an influenza viral vector Brucella abortus vaccine induces a long-term protective immune response against Brucella abortus infection.
    Tabynov K; Yespembetov B; Ryskeldinova S; Zinina N; Kydyrbayev Z; Kozhamkulov Y; Inkarbekov D; Sansyzbay A
    Vaccine; 2016 Jan; 34(4):438-444. PubMed ID: 26709638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermediate rough Brucella abortus S19Δper mutant is DIVA enable, safe to pregnant guinea pigs and confers protection to mice.
    Lalsiamthara J; Gogia N; Goswami TK; Singh RK; Chaudhuri P
    Vaccine; 2015 May; 33(22):2577-83. PubMed ID: 25869887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Persistence of brucellosis L cultures in the body of an experimental animal and the duration of immunity].
    Vershilova PA; Grekova NA; Tolmacheva TA
    Vestn Akad Med Nauk SSSR; 1985; (3):10-3. PubMed ID: 3922151
    [No Abstract]   [Full Text] [Related]  

  • 17. [On the question of the necessity of changing place of work in brucella infection and following residual brucellosis].
    Töppich E; Krüger W
    Z Gesamte Inn Med; 1966 Jun; 21(12):372-4. PubMed ID: 6011096
    [No Abstract]   [Full Text] [Related]  

  • 18. A recent trial comparing two 45/20 adjuvant Brucella vaccines.
    McKeon FW
    Dev Biol Stand; 1976; 31():343-50. PubMed ID: 816690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Brucella melitensis Rev. 1 and Brucella abortus 45-20 vaccines in goats: serologic tests.
    Jones LM; García-Carrillo C; Alton GG
    Am J Vet Res; 1973 Feb; 34(2):199-202. PubMed ID: 4631096
    [No Abstract]   [Full Text] [Related]  

  • 20. Selection of a Brucella vaccine strain of low residual virulence by chemical mutagenesis.
    Zhao WR; Wendoso ; Hasi ; Qin YX; Weng W; Lu SL
    J Med Microbiol; 1989 Oct; 30(2):143-8. PubMed ID: 2795638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.